Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas

Status Recruiting

Clinical Trial Summary

Prognostic Importance of Quantitative Magnetic Resonance Imaging for Evaluation of Pancreatic Steatosis in Patients with Pancreatic Cancer

Clinical Trial Description

1. Finding patients with pancreatic cancer (in all stages), before any treatment.

2. Non invasively quantify fatty infiltration of pancreas using, MRI DIXON Scan in pancreatic cancer patient relatively to liver.

3. Measuring cell-free blood DNA in those patients for evaluating the aggressiveness of the disease.

4. Quantify the prognostic significance of pancreatic steatosis in comparison with clinical and pathological prognostic indexes used today. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02682394
Study type	Observational
Source	Soroka University Medical Center
Contact	Vladimir Borodetsky, MD
Phone	+972547428882
Email	zivova1982@gmail.com
Status	Recruiting
Phase	N/A
Start date	September 2015
Completion date	October 2017

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02902484` - Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer	Phase 1/Phase 2
Completed	`NCT04008537` - Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device	N/A
Recruiting	`NCT04809935` - EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy	Phase 4
Not yet recruiting	`NCT03659292` - Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy	N/A
Completed	`NCT03150615` - Enteral Nutrition After Pancreaticoduodenectomy	N/A
Recruiting	`NCT05566743` - A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas	Phase 2
Not yet recruiting	`NCT04049461` - Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer
Recruiting	`NCT04164602` - The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
Active, not recruiting	`NCT04128332` - Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer	N/A
Recruiting	`NCT03536793` - Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
Recruiting	`NCT02311439` - Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas	Phase 2/Phase 3
Completed	`NCT02296736` - The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan
Withdrawn	`NCT04123574` - A Pilot Study of BXCL701 in Patients With Pancreatic Cancer	Early Phase 1
Not yet recruiting	`NCT03278015` - Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients	Phase 2
Active, not recruiting	`NCT02905578` - A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)	Phase 2
Completed	`NCT01446458` - Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer	Phase 1
Recruiting	`NCT04677244` - Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level	N/A
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Recruiting	`NCT06148298` - Cell-Free DNA CHIP for Diagnosing Cancer
Terminated	`NCT03451773` - M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas	Phase 1/Phase 2